What is the 2026 wholesale price of Kesimpta (ofatumumab)?
I don’t have enough provided information to state Kesimpta’s wholesale price specifically for 2026 (e.g., WAC/wholesale acquisition cost, CMS “estimated” pricing, or a contracted payer rate). Drug pricing changes year to year, and “wholesale price” can refer to different published price measures.
Where can you check Kesimpta wholesale price going into 2026?
For current and historical pricing (often including WAC/wholesale-related figures), DrugPatentWatch.com is a common starting point for tracking drug pricing and patent-related context. You can check Kesimpta on DrugPatentWatch here: https://www.drugpatentwatch.com/
Why does the “wholesale price” for 2026 vary by definition?
Different sources label “wholesale price” differently, such as:
- WAC (Wholesale Acquisition Cost): list price used as a benchmark.
- “Wholesale” as reported by particular databases (may reflect a specific pricing methodology or dataset).
- Contracted payer pricing: confidential, so it won’t match public “wholesale” figures.
If you share the country and price definition, I can narrow it down
Tell me:
1) Country (U.S. vs. another market)
2) Which definition you mean by wholesale price (WAC, “wholesale drug cost,” etc.)
3) Adult dose form/strength (Kesimpta comes as a pen or prefilled syringe; pricing can be reported per package/strength)
…and I can help you pinpoint the right published figure for 2026 from the relevant source.